Literature DB >> 2960564

Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women.

M Brochu1, A Bélanger, R R Tremblay.   

Abstract

In the present study, the authors measured the plasma levels of unconjugated and glucuronide (G) derivatives of C-19 steroids in hirsute women divided into two groups, depending upon their dehydroepiandrosterone sulfate (DHEAS). This quite restrictive classification was the result of an arbitrary decision of the authors, who wanted to focus interpretation of their data on DHEAS, the well-known adrenal androgen. In the hyperandrogenic hirsute woman (HH), the DHEAS levels were higher than 3.0 micrograms/ml; in idiopathic hirsute women (IH), values of DHEAS were comparable to those observed in normal women (1.2 to 2.5 micrograms/ml). In the HH group, the levels of dehydroepiandrosterone, androstenedione, androst-5-ene-3 beta,17 beta-diol (delta 5-diol), testosterone, dihydrotestosterone (DHT), androstane-3 alpha, 17 beta-diol (3 alpha-diol), androstane-3 beta,17 beta-diol (3 beta-diol), androsterone (ADT), DHTG, 3 alpha-diol-G, 3 beta-diol-G, and ADTG were higher than the normal range whereas, in the IH group, only delta 5-diol, DHT, 3 beta-diol-G and ADTG were elevated. These data are compatible with the hypothesis that the plasma levels of steroid G represent the peripheral formation of androgen in target tissues. Because the pattern of androgen metabolism is most probably changed in many cases of hirsutism, these data suggest that for research purposes, it would be preferable to measure 3 beta-diol-G and ADTG in addition to 3 alpha-diol-G in order to gain additional information concerning androgen metabolites in this disorder.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960564     DOI: 10.1016/s0015-0282(16)59589-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

Review 1.  Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

2.  Plasma 3 alpha-androstanediol glucuronide in precocious adrenarche.

Authors:  R Balducci; G Finocchi; A Mangiantini; P Bianchi; R Guglielmi; V Toscano
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

3.  Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome.

Authors:  Li-Wei Cho; Thozhukat Sathyapalan; Eric S Kilpatrick; Brian G Keevil; Adrian G Miller; Anne M Coady; Lina Ahmed; Stephen L Atkin
Journal:  BMC Endocr Disord       Date:  2017-05-19       Impact factor: 2.763

4.  Unraveling the functional role of the orphan solute carrier, SLC22A24 in the transport of steroid conjugates through metabolomic and genome-wide association studies.

Authors:  Sook Wah Yee; Adrian Stecula; Huan-Chieh Chien; Ling Zou; Elena V Feofanova; Marjolein van Borselen; Kit Wun Kathy Cheung; Noha A Yousri; Karsten Suhre; Jason M Kinchen; Eric Boerwinkle; Roshanak Irannejad; Bing Yu; Kathleen M Giacomini
Journal:  PLoS Genet       Date:  2019-09-25       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.